How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

4,762 results for

Cardiogenic Shock

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Emergency Valve-in-Valve Transcatheter Aortic Valve Implantation for the Treatment of Acute Stentless Bioprosthetic Aortic Insufficiency and Cardiogenic Shock Full Text available with Trip Pro

Emergency Valve-in-Valve Transcatheter Aortic Valve Implantation for the Treatment of Acute Stentless Bioprosthetic Aortic Insufficiency and Cardiogenic Shock Bioprosthetic aortic valve degeneration may present as acute, severe aortic regurgitation and cardiogenic shock. Such patients may be unsuitable for emergency valve replacement surgery due to excessive risk of operative mortality but could be treatable with transfemoral valve-in-valve transcatheter aortic valve implantation (TAVI (...) ). There is a paucity of data regarding the feasibility of valve-in-valve TAVI in patients presenting with cardiogenic shock due to acute aortic insufficiency from stentless bioprosthetic valve degeneration. We present one such case, highlighting the unique aspects of valve-in-valve TAVI for this challenging patient subset.

2018 Case reports in cardiology

142. Microcirculation in cardiogenic shock supported with extracorporeal membrane oxygenation: the need for a homogeneous population and strict evolution assessment Full Text available with Trip Pro

Microcirculation in cardiogenic shock supported with extracorporeal membrane oxygenation: the need for a homogeneous population and strict evolution assessment

2018 Critical Care

143. Trends, Predictors, and Outcomes of Temporary Mechanical Circulatory Support for Postcardiac Surgery Cardiogenic Shock. (Abstract)

Trends, Predictors, and Outcomes of Temporary Mechanical Circulatory Support for Postcardiac Surgery Cardiogenic Shock. Postcardiac surgery cardiogenic shock (PCCS) is seen in 2% to 6% of patients who undergo cardiac surgery. There are limited large-scale data on the use of mechanical circulatory support (MCS) in these patients. This study sought to evaluate the in-hospital mortality, trends, and resource utilization for PCCS admissions with and without MCS. A retrospective cohort of PCCS

2018 American Journal of Cardiology

144. Hospital mortality and thirty day readmission among patients with non-acute myocardial infarction related cardiogenic shock. (Abstract)

Hospital mortality and thirty day readmission among patients with non-acute myocardial infarction related cardiogenic shock. Cardiogenic shock (CS) in absence of acute myocardial infarction (AMI) has significant morbidity and mortality. This population of patients has been excluded from prior major randomized trials and observational studies.We included patients with CS in absence of AMI from the 2013-14 HCUP's National Readmission Database. 30-day readmissions were studied and etiology

2018 International journal of cardiology

145. Adenosine Plasma Level and A2A Receptor Expression in Patients With Cardiogenic Shock. Full Text available with Trip Pro

Adenosine Plasma Level and A2A Receptor Expression in Patients With Cardiogenic Shock. To investigate whether adenosine A2A receptors lead to vasodilation and positive inotropic function under stimulation and whether they play a role in the control of blood pressure in patients with cardiogenic shock.Prospective observational study.Monocentric, Hopital Nord, Marseille, France.Patients with cardiogenic shock (n = 16), acute heart failure (n = 16), and acute myocardial infarction (n = 16 (...) ).None.Arterial adenosine plasma level and A2A receptor expression on peripheral blood mononuclear cells were evaluated by mass spectrometry and Western blot, respectively, at admission and after 24 hours. Hemodynamic parameters, including systemic vascular resistance, were also assessed. Mean adenosine plasma level at admission was significantly higher in patients with cardiogenic shock (2.74 ± 1.03 µM) versus acute heart failure (1.33 ± 0.27) or acute myocardial infarction (1.19 ± 0.27) (normal range, 0.4

2018 Critical Care Medicine

146. Aortic stenosis complicated by cardiogenic shock treated by transcatheter aortic valve replacement with extracorporeal membrane oxygenation: A case report. Full Text available with Trip Pro

Aortic stenosis complicated by cardiogenic shock treated by transcatheter aortic valve replacement with extracorporeal membrane oxygenation: A case report. Cardiogenic shock secondary to aortic stenosis (AS) is a challenging problem owing to the high mortality associated with treatment, and successful treatment of such patients has been rare.A 77-year-old man presented with exercise intolerance and progressive exertional dyspnea and chest pain. The patient was suffered from cardiogenic shock (...) and the left ventricular ejection fraction had risen from 20% to 50%.Patients with cardiogenic shock secondary to AS are very difficult to treat medically. ECMO with TAVR may be a reasonable strategy.

2018 Medicine

147. Microcirculation in Cardiogenic Shock

Microcirculation in Cardiogenic Shock Microcirculation in Cardiogenic Shock - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Microcirculation in Cardiogenic Shock (MicroShock) The safety and scientific (...) or disease Intervention/treatment Hospital Rapid Response Team Activation Other: No intervention Study Design Go to Layout table for study information Study Type : Observational Estimated Enrollment : 100 participants Observational Model: Cohort Time Perspective: Prospective Official Title: Study of Microcirculation in Cardiogenic Shock Estimated Study Start Date : May 2018 Estimated Primary Completion Date : March 2020 Estimated Study Completion Date : March 2020 Resource links provided by the National

2018 Clinical Trials

148. Impella CP With VA ECMO for Cardiogenic Shock

Impella CP With VA ECMO for Cardiogenic Shock Impella CP With VA ECMO for Cardiogenic Shock - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Impella CP With VA ECMO for Cardiogenic Shock (REVERSE) The safety (...) ): Michael Ibrahim, University of Pennsylvania Study Details Study Description Go to Brief Summary: Veno-arterial extra-corporeal membrane oxygenation (VA-ECMO) is indicated as a haemodynamic rescue strategy in decompensated acute or chronic heart failure presenting as cardiogenic shock. It has been used across aeitologies including post-myocardial infarction, dilated cardiomyopathy, acute myocarditis and in post-cardiotomy shock. VA ECMO has a number of effects on the circulation including improved end

2018 Clinical Trials

149. Efficacy and Safety on Heart Rate Control With Ivabradine on Cardiogenic Shock

Efficacy and Safety on Heart Rate Control With Ivabradine on Cardiogenic Shock Efficacy and Safety on Heart Rate Control With Ivabradine on Cardiogenic Shock - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Efficacy and Safety on Heart Rate Control With Ivabradine on Cardiogenic Shock (ES-FISH) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03437369 Recruitment Status : Not yet recruiting First Posted : February 19, 2018 Last

2018 Clinical Trials

150. Out of hospital extracorporeal life support (ECLS) implantation in cardiogenic shock after cardiac arrest - A case report. (Abstract)

Out of hospital extracorporeal life support (ECLS) implantation in cardiogenic shock after cardiac arrest - A case report. We report the use of out-of-hospital extracorporeal life support (ECLS) in a 62-year-old patient with severe cardiogenic shock after cardiac arrest. The patient was successfully stabilized using the ECLS system in the pre-hospital setting. Hospital discharge with a good neurological outcome was possible after 23days.Copyright © 2018 Elsevier Inc. All rights reserved.

2018 American Journal of Emergency Medicine

151. Diabetes Mellitus and Cardiogenic Shock Complicating Acute Myocardial Infarction. (Abstract)

Diabetes Mellitus and Cardiogenic Shock Complicating Acute Myocardial Infarction. Diabetes mellitus (diabetes) increases the risk of acute myocardial infarction, which can result in cardiogenic shock. Data on the relation of diabetes and the occurrence and prognosis of cardiogenic shock postacute myocardial infarction are scant.Among the National Inpatient Sample patients aged ≥18 years and hospitalized for acute myocardial infarction during the 2012-2014 period, we examined the association (...) between diabetes and the incidence and outcomes of cardiogenic shock complicating acute myocardial infarction, using multivariable logistic and linear regression models.Of 1,332,530 hospitalizations for acute myocardial infarction, 72,765 (5.5%) were complicated by cardiogenic shock. In acute myocardial infarction patients, cardiogenic shock incidence was higher among those with vs without diabetes (5.8% vs 5.2%; adjusted odds ratio [aOR] 1.14; 95% confidence interval [CI], 1.11-1.19; P < .001

2018 American Journal of Medicine

152. Causes and Predictors of 30-Day Readmission in Patients With Acute Myocardial Infarction and Cardiogenic Shock. Full Text available with Trip Pro

Causes and Predictors of 30-Day Readmission in Patients With Acute Myocardial Infarction and Cardiogenic Shock. Acute myocardial infarction (AMI) occurs as a result of irreversible damage to cardiac myocytes secondary to lack of blood supply. Cardiogenic shock complicating AMI has significant associated morbidity and mortality, and data on postdischarge outcomes are limited.We derived the study cohort of patients with AMI and cardiogenic shock from the 2013 to 2014 Healthcare Cost (...) and Utilization Project National Readmission Database. Incidence, predictors, and causes of 30-day readmissions were analyzed. From 43 212 index admissions for AMI with cardiogenic shock, 26 016 (60.2%) survived to discharge and 5277 (20.2% of survivors) patients were readmitted within 30 days. More than 50% of these readmissions occurred within first 10 days. Cardiac causes accounted for 42% of 30-day readmissions (heart failure 20.6%; acute coronary syndrome 11.6%). Among noncardiac causes, respiratory

2018 Circulation. Heart failure

153. Usefulness of Intra-aortic Balloon Pump in Patients With Cardiogenic Shock. (Abstract)

Usefulness of Intra-aortic Balloon Pump in Patients With Cardiogenic Shock. Predictors of survival in cardiogenic shock (CS) treated with intra-aortic balloon pump (IABP) are not clearly understood. In this retrospective study, we sought to evaluate patient characteristics and impact of timing of IABP in treatment of CS. Patients presenting to the Yale New Haven Hospital in CS who received IABP between February 2013 and April 2017 were included in the study. We assessed baseline characteristics

2018 American Journal of Cardiology

154. Adrenergic cardiomyopathy and cardiogenic shock as initial presentation of pheochromocytoma. A case report and review of the literature Full Text available with Trip Pro

Adrenergic cardiomyopathy and cardiogenic shock as initial presentation of pheochromocytoma. A case report and review of the literature Pheochromocytomas are infrequent tumors arised from the chromaphine cells of the adrenal sympathetic system. The excess of circulating catecholamines may lead to different cardiovascular disorders from silent alterations of the myocardial conduction to different forms of cardiomyopathy. The onset as cardiogenic shock is exceptional.A 35-year-old male (...) presentation. The onset as cardiogenic shock is exceptional. The differential diagnosis of a patient with cardiogenic shock of unknown origin should consider the presence of an underlying pheocromocytoma as well as other states of adrenergic hyperstimulation. The reversibility of the myocardial affection in pheocromocytoma-associated myocardiopathy is common after the tumor resection.Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

2018 International journal of surgery case reports

155. Extracorporeal Membrane Oxygenation Support for Incessant Tachyarrhythmia-Induced Severe Cardiogenic Shock Full Text available with Trip Pro

Extracorporeal Membrane Oxygenation Support for Incessant Tachyarrhythmia-Induced Severe Cardiogenic Shock 30127234 2019 03 21 2542-5641 131 17 2018 09 05 Chinese medical journal Chin. Med. J. Extracorporeal Membrane Oxygenation Support for Incessant Tachyarrhythmia-Induced Severe Cardiogenic Shock. 2139-2140 10.4103/0366-6999.239298 Zhang Zhi-Ping ZP Department of Cardiology, Wuhan Asia Heart Hospital, Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei 430022, China. Su Xi

2018 Chinese medical journal

156. Predictors of successful weaning from veno-arterial extracorporeal membrane oxygenation in adult patients with cardiogenic shock or cardiac arrest: systematic review and meta-analysis

Predictors of successful weaning from veno-arterial extracorporeal membrane oxygenation in adult patients with cardiogenic shock or cardiac arrest: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2020 PROSPERO

157. Shenfu injection for cardiogenic shock: a systematic review and meta-analysis of randomized controlled trials

Shenfu injection for cardiogenic shock: a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2020 PROSPERO

158. Meta-Analysis and Trial Sequential Analysis of Multivessel PCI versus Culprit Artery Only PCI in ST-Elevation Myocardial Infarction without Cardiogenic Shock

Meta-Analysis and Trial Sequential Analysis of Multivessel PCI versus Culprit Artery Only PCI in ST-Elevation Myocardial Infarction without Cardiogenic Shock Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2020 PROSPERO

159. Comparative efficacy and safety of left ventricular unloading strategies during venoarterial extracorporeal membrane oxygenation in patients with cardiogenic shock: a systematic review and network meta-analysis

Comparative efficacy and safety of left ventricular unloading strategies during venoarterial extracorporeal membrane oxygenation in patients with cardiogenic shock: a systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD

2020 PROSPERO

160. Efficacy and safety of Impella 5.0 in cardiogenic shock: an updated systematic review and meta-analysis

Efficacy and safety of Impella 5.0 in cardiogenic shock: an updated systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2020 PROSPERO

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>